Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/99024
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wagstaff, M. | - |
dc.contributor.author | Driver, S. | - |
dc.contributor.author | Coghlan, P. | - |
dc.contributor.author | Greenwood, J. | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Wound Repair and Regeneration, 2014; 22(2):205-211 | - |
dc.identifier.issn | 1067-1927 | - |
dc.identifier.issn | 1524-475X | - |
dc.identifier.uri | http://hdl.handle.net/2440/99024 | - |
dc.description.abstract | The objectives of the study were (1) to look for any local, clinically apparent response, within and around a debrided wound, to a novel biocompatible polyurethane foam during repeated, short-term implantation, and (2) to assess the material's efficacy as a negative pressure wound therapy (NPWT) interface compared with a widely used, commercially available foam. Twenty pressure ulcers in 18 patients underwent surgical debridement, then randomization to receive novel treatment or control foam as the wound interface for NPWT. Dressing changes every 2-3 days allowed qualitative wound assessment and quantitative measurement to compare outcomes. No adverse reaction was observed in any patient receiving the new foam. The new "novel foam" performed as a NPWT interface as effectively as the control "standard foam." In deep wounds, the new foam was easier to remove, fragmented less, and showed less retention than the control foam. No marginal in-growth occurred, making removal less traumatic and reducing bleeding from cavity wall granulations. The results support previous large animal studies, and independent ISO10993 testing, that the new foam is safe and biocompatible. Its efficacy as an NPWT interface, nontraumatic removal with low fragmentation and retention rate, favors the new material, especially in deep cavity wounds. | - |
dc.description.statementofresponsibility | Marcus James Dermot Wagstaff, Sara Driver, Patrick Coghlan, John Edward Greenwood | - |
dc.language.iso | en | - |
dc.publisher | Wiley | - |
dc.rights | © 2014 by the Wound Healing Society | - |
dc.source.uri | http://dx.doi.org/10.1111/wrr.12146 | - |
dc.subject | Granulation Tissue | - |
dc.subject | Humans | - |
dc.subject | Polyurethanes | - |
dc.subject | Biocompatible Materials | - |
dc.subject | Pain Measurement | - |
dc.subject | Treatment Outcome | - |
dc.subject | Follow-Up Studies | - |
dc.subject | Pilot Projects | - |
dc.subject | Bandages | - |
dc.subject | Wound Healing | - |
dc.subject | Time Factors | - |
dc.subject | Molecular Sequence Data | - |
dc.subject | Adolescent | - |
dc.subject | Adult | - |
dc.subject | Aged | - |
dc.subject | Middle Aged | - |
dc.subject | Pressure Ulcer | - |
dc.subject | Female | - |
dc.subject | Male | - |
dc.subject | Negative-Pressure Wound Therapy | - |
dc.title | A randomized, controlled trial of negative pressure wound therapy of pressure ulcers via a novel polyurethane foam | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1111/wrr.12146 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Wagstaff, M. [0000-0003-3160-3720] | - |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.